Clinical Trials Logo

Photocoagulation Burn to Retina clinical trials

View clinical trials related to Photocoagulation Burn to Retina.

Filter by:
  • None
  • Page 1

NCT ID: NCT04062370 Not yet recruiting - Clinical trials for Retinal Vein Occlusion

Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion

Start date: October 1, 2019
Phase: Phase 4
Study type: Interventional

Retinal vein occlusion (RVO) may lead to series of complications including retinal ischemia, macular edema (ME) and induce vision impairment. Intravitreal injection of Ranibizumab (0.5mg) has been proved to be a safe and effective method for the treatment of RVO-ME. In this study, different treatment regimens of Ranibizumab is applied and the effects is observed at 1-6 months to explore the best regimen for RVO. After 6 months, anti-VEGF therapy and/or laser photocoagulation is used to explore whether laser photocoagulation can maintain the therapeutic effect of Ranibizumab or reduce the injection number.